President Donald Trump on Monday designated illicit fentanyl as a "weapon of mass destruction" in an executive order. The ...

Trump reclassifying the drug as Schedule 3 would allow further medical research to be done at the federal level and loosen ...

The main practical benefits would be tax relief for the cannabis industry and fewer barriers to medical research.

Tilray Brands, Inc. has crossed an important threshold toward sustainable earnings and cash discipline. Click for what Class ...

U.S.-listed cannabis stocks are back in focus as expectations build around a potential shift in federal marijuana policy.

Trump's decision to move marijuana to Schedule III could ease taxes and expand medical access, but industry leaders warn it ...

The U.S. Attorney's Office has reached a civil settlement with a Santa Teresa business owner over alleged violations of ...

R.I., are urging the Drug Enforcement Administration to extend federal telemedicine flexibilities for prescribing controlled substances before they expire Dec. 31. In a Dec. 2 letter to DEA ...

SAN FRANCISCO — Two California-based healthcare technology executives were convicted Tuesday by a federal jury for illegally distributing Adderall online by building a billion-dollar company that ...

Lev Facher covers the U.S. addiction and overdose crisis. The Trump administration appears poised to extend a temporary, Covid-era rule allowing health providers to prescribe certain controlled ...